http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-067159-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
filingDate 2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-067159-A1
titleOfInvention OXADIAZOL-PYRIDINONE COMPOUND, PROCESS FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
abstract An oxadiazol-pyridinone compound of formula (1): wherein: R1 is selected from the group consisting of halogen, trifluoromethyl, methyl and methoxy, and R2 is hydrogen, or R1 and R2 together form a condensed phenyl; R3 is selected from the group consisting of hydrogen, halogen, trifluoromethyl, methyl, alkoxy, optionally substituted phenyl, trifluorhenyloxy, heterocyclyl, dialkylamino and -N (CH3) CH2CH2OCH3; R4 is selected from the group consisting of hydrogen, halogen, trifluorornetyl, methyl and methoxy; R5 is hydrogen, methyl or methoxy; n is 0, 1 or 2; and R6 and R7 together form a six-membered fused aromatic ring that is optionally substituted and contains 0, 1 or 2 nitrogen atoms; with the proviso that, if R2 is hydrogen, at least one of R3 and R4 is not hydrogen, or a pharmaceutically acceptable salt thereof. A process for the preparation of said compound. Pharmaceutical composition that includes it and its use for the manufacture of a useful drug for the treatment of migraines, headaches or cluster headaches.
priorityDate 2007-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 17.